Effective electroporation therapy of human pancreatic tumors implanted in nude mice

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 4, Issue 4, 1997, Pages 293-299

  Dev, S B ^a   Nanda, G S ^a   An, Z ^b   Wang, X ^b   Hoffman, R M ^b   Hofmann, G A ^a  

^a Inovio Biomedical Corporation   (United States)

^b ANTICANCER INC   (United States)

Author keywords

Bleomycin and tumor; Electrochemotherapy; Electropotation therapy; Pancreatic cancer

Indexed keywords

BLEOMYCIN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; ELECTROCHEMOTHERAPY; INTRATUMORAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS TUMOR; PRIORITY JOURNAL; TUMOR REGRESSION;

EID: 0031424317     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549709052016     Document Type: Article

References (26)

1. Belehradek, J. J., Orlowski, S., Poddevin, B., Paoletti, C., and Mir, L. M. 1991. Electrochemotherapy of spontaneous mammary tumors in mice. Eur. J. Cancer 27:73-76.
2. Belehradek, M., Domenge, C., Luboinski, B., Orlowski, S., Belehradek, J. J., and Mir, L. M. 1993. Electrochemotherapy, a new antitumor treatment. Cancer 72:3694-3700.
3. Dev, S. B., and Hofmann, G. A. 1994. Electrochemotherapy - a novel method of cancer treatment. Cancer Treat. Rev. 20:105-115.
4. Domenge, C., Orlowski, S., Luboinski, B., DeBaere, T., Schwaab, G., Belehradek, J., and Mir, L. M. 1996. Antitumor electrochemotherapy: New advances in the clinical protocol. Cancer 77:956-963.
5. Gansauge, F., Link, K. H., Rilinger, N., Kunz, R., and Beger, H. G. 1995. Regional chemotherapy in advanced pancreatic carcinoma. Med. Klin. 90:501-505.
6. Heller, R., Jaroszeski, M. J., Atkin, A., Moradpour, D., Gilbert, R. A., Wands, J., and Nicolau, C. 1996a. In vivo gene electroinjection and expression in rat liver. FEBS Lett. 389:225-228.
7. Heller, R., Jaroszeski, M. J., Glass, L. F., Messina, J. L., and Rapaport, D. P. 1996b. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 77:964-966.
8. Heller, R., Jaroszeski, M. J., Leo-Messina, J., Perrott, R., Van Voorhis, N., Reintgen, D. S., and Gilbert, R. A. 1995. Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem. Bioenerg. 36:83-87.
9. Hofmann, G. A., Dev, S. B., and Nanda, G. S. 1996. Electrochemotherapy: Transition from laboratory to the clinic. IEEE Eng. Med. Biol. 15:124-132.
10. Jain, R. K. 1994. Barriers to drug delivery in solid tumors. Sci. Am. 271(1):58-65.
11. Jaroszeski, M. J., Gilbert, R. A., Yeatman, T., Nicolau, C., Atkin, A., and Heller, R. 1996. In vivo electroporation for delivery of molecules to cells. Proc. Am. Assoc. Cancer Res. 37:351. Abstract 2398.
12. Kanesada, H. 1990. Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma, in vivo. J. Jpn. Soc. Cancer Ther. 25:2640-2648.
13. Kinosita, K. J., and Tsong, T. Y. 1979. Voltage induced formation and hemolysis of human erythocytes. Biochim. Biophys. Acta 471:227-242.
14. Mansouri, A., Henle, K. J., Nutt, A. K., and Nagle, W. A. 1991. New approaches to the study of tumor drug resistance. SAAS Bull. Biochem. Biotechnol. 4:13-16.
15. Mir, L. M., Banoun, H., and Paoletti, C. 1988. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: Direct access to the cytosol. Exp. Cell Res. 175:15-25.
16. Mir, L. M., Belehradek, M., Domenge, C., Orlowski, S., Poddevin, B., Belehradek, J. J., Schwaab, G., Luboinski, B., and Paoletti, C. 1991. Electrochemotherapy, a novel antitumor treatment: First clinical trial. C.R. Acad. Sci. Paris III 313:613-618.
17. Nishi, T., Yoshizato, K., Yamashiro, S., Takeshima, H., Sato, K., Hamada, K., Kitamura, I., Yoshimura, T., Saya, H., Kuratsu, J., and Ushio, Y. 1996. High efficiency in vivo gene transfer using intra arterial plasmid DNA injection following in vivo electroporation. Can. Res. 56:1050-1055.
18. Okino, M., and Mohri, H. 1987. Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn. J. Cancer Res. 78:1319-1321.
19. Okino, M., Tomie, H., Kanesada, H., Marumoto, M., Esato, K., and Suzuki, H. 1992. Optimal electric conditions in electrical impulse chemotherapy. Jpn. J. Cancer Res. 83:1095-1101.
20. Orlowski, S., Belehradek, J. J., Paoletti, C., and Mir, L. M. 1988. Transient electropermeabilization of cells in culture: Increase of the cytotoxicity of anticancer drugs. Biochem. Pharmacol. 37:4727-4733.
21. Poston, G. J., Gillespie, J., and Guillou, P. J. 1991. Biology of pancreatic cancer. Gut 32:800-812.
22. Reintgen, D. S., Jaroszeski, M. J., and Heller, R. 1996. Electrochemotherapy, a novel approach to cancer. Skin Cancer Found. J. 14:17-19, 83.
23. Rudolf, Z., Stabuc, B., Cemazar, M., Miklavcic, D., Vodovnik, L., and Sersa, G. 1995. Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients. Radiol. Oncol. 29:229-235.
24. Salford, L. G., Persson, B. R. R., Brun, A., Ceberg, C. P., Kongstad, P., and Mir, L. M. 1993. A new brain tumor therapy combining bleomycin with in vivo electropermeabilization. Biochem. Biophys. Res. Commun. 194:938-943.
25. Sersa, G., Cemazar, M., and Miklavcic, D. 1995. Antitumor effectiveness of electrochemotherapy with cis-diaminedichloroplatinum (II) in mice. Cancer Res. 55:3450-3455.
26. Tounekti, O., Pron, G., Belehradek, J., and Mir, L. M. 1993. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res. 53:5462-5469.